1. MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children’s oncology group
   Risa Niemas-Teshiba et al, 2018, Oncotarget CrossRef
2. Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma
   Santiago Zugbi et al, 2020, Cancers CrossRef